Skip to main content

DAFNA Capital Management LLC

Position in RCUS — Arcus Biosciences, Inc.

CIK 1389933 LOS ANGELES, CA

Position in RCUS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$9,586,706
-$691,864 QoQ
Shares Held
443,829
+2.9% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
2.51%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RCUS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DAFNA Capital Management LLC holds $266,664,368 across 58 Biotechnology names. RCUS ranks #7 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 RCUS
Arcus Biosciences, Inc.
This page
443,829 $9,586,706

All Filings in RCUS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,586,706 443,829
2025-12-31 $10,278,570 431,329
2025-09-30 $8,535,713 627,626
2025-06-30 $5,108,875 627,626
2025-03-31 $4,907,239 625,126
2024-12-31 $3,785,291 254,217
2024-09-30 $3,925,202 256,717
2024-06-30 $3,856,494 253,217
2024-03-31 $4,374,816 231,717
2023-12-31 $4,444,894 232,717
2023-09-30 $3,997,770 222,717
2023-06-30 $4,584,312 225,717
2023-03-31 $3,195,958 175,217
2022-12-31 $2,941,047 142,217
2022-09-30 $4,675,236 178,717
2022-06-30 $4,756,748 187,717
2022-03-31 $4,583,048 145,217
2021-12-31 $4,743,084 117,200
2021-09-30 $4,313,419 123,700
2021-06-30 $3,286,962 119,700
2021-03-31 $1,617,408 57,600
2020-12-31 $1,287,616 49,600
2020-09-30 $1,235,794 72,100
2020-06-30 $1,783,754 72,100
2020-03-31 $385,836 27,798